PVF 109 – Rev 1_May 2024 ADR Consumer reporting form_Landscape

PVF 76 Rev_2 May 2024 Annual Progress Reporting Form

PVF83 Rev 1 _Jan 2023 APPLICATION FOR ADDITIONAL INVESTIGATOR (S) CHANGE OF INVESTIGATOR (S) OR ADDITIONAL CLINICAL TRIAL SITES

PVF 82 Rev 1_January 2023 Application for a Clinical Trial Protocol Amendment

PVF 79 Rev_1 September 2022 Joint Declaration By Sponsor And Principal Investigator Concerning Sufficient Funds To Complete Study

PVF 78 Rev 1_January 2023 Recommended Format For Cvs Of Individuals Participating In Clinical Trials

PVF 30 Rev 5_November 2022 Applicants Contact Details Update Form

PVF 27 Rev 5_July 2023 Meeting Request Form

PVF 17 Rev 1_July 2023 Medicines-Safety-and-Monitoring-Form-for-COVID-19-Prophylaxis

PVF 16 Rev 1_July 2023 Medicines Safety and Monitoring Form for COVID-19 Treatment

PVF 01 Rev 9_September 2022 Spontaneous ADR Report Form

PVF 81 Rev 1_September 2022 Declaration By Co- And Sub-Investigators For GCP Compliance

PVF 80 Rev 1_September 2022 Declaration By Principal Investigator For GCP Compliance

PVF 79 Rev_1 September 2022 Joint Declaration By Sponsor And Principal Investigator Sufficient Funds

PVF 55_Rev_3_July_2022_Submission_Declaration_by_Investigators